According to BioNTech's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 5.34651. At the end of 2023 the company had a P/S ratio of 6.09.
Year | P/S ratio | Change |
---|---|---|
2023 | 6.09 | 207.97% |
2022 | 1.98 | -30.28% |
2021 | 2.84 | -91.6% |
2020 | 33.7 | -46.68% |
2019 | 63.3 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |